Investing.com - Protalix (NYSE: PLX) reported third quarter EPS of $-0.040, in line with the analyst estimate of $-0.040. Revenue for the quarter came in at $10.34M versus the consensus estimate of $10M.
Protalix's stock price closed at $1.850. It is down -2.120% in the last 3 months and up 79.610% in the last 12 months.
Protalix saw positive EPS revisions and negative EPS revisions in the last 90 days. See Protalix's stock price’s past reactions to earnings here.
According to InvestingPro, Protalix's Financial Health score is "great performance".
Check out Protalix's recent earnings performance, and Protalix's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar